OncBioMune Adds Capital Markets Leader Daniel Hoverman to Board of Directors
BATON ROUGE, LA--(Marketwired - January 05, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of novel cancer products and a …